Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-26-335822
Filing Date
2026-08-06
Accepted
2026-08-05 19:00:46
Documents
82
Period of Report
2026-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q odtx-20260630.htm   iXBRL 10-Q 3707494
2 EX-31.1 odtx-ex31_1.htm EX-31.1 20988
3 EX-31.2 odtx-ex31_2.htm EX-31.2 20887
4 EX-32.1 odtx-ex32_1.htm EX-32.1 10727
5 EX-32.2 odtx-ex32_2.htm EX-32.2 10723
  Complete submission text file 0001193125-26-335822.txt   12475768

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT odtx-20260630.xsd EX-101.SCH 1281246
86 EXTRACTED XBRL INSTANCE DOCUMENT odtx-20260630_htm.xml XML 2326589
Mailing Address 51 SLEEPER STREET BOSTON MA 02210
Business Address 51 SLEEPER STREET BOSTON MA 02210 (212) 841-1000
Odyssey Therapeutics, Inc. (Filer) CIK: 0001882782 (see all company filings)

EIN.: 863384382 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-43270 | Film No.: 261245373
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)